COVID-19

Browse COVID-19 Content

Press Releases and Statements

CHPA applauds FDA’s recent emergency use authorization for a number of over-the-counter (OTC) nonprescription self-testing products for COVID-19.

Apr 2, 2021

Press Releases and Statements

Recent media reports have cited infectious disease experts who recommend against premedicating with over-the-counter (OTC) pain relievers, like those containing acetaminophen and ibuprofen, when getting a COVID-19 vaccine.

Feb 4, 2021

Article

For its annual year-in-review series, Chain Drug Review featured CHPA's President & CEO, Scott Melville, who offered industry insights from last year and thoughts on the outlook for 2021.

Jan 7, 2021

Submission

Supply chain resilience is essential to assure consumer healthcare products Americans depend on remain widely available, including in times of disease outbreaks or global crises.

Dec 23, 2020

Press Releases and Statements

Expert insights on the importance of proactive health maintenance, including addressing nutrient deficiencies that increase risk of infection and disease.

Dec 15, 2020

Press Releases and Statements

When used appropriately melatonin can play an important role in personal healthcare, but inappropriate use of supplements could be harmful. Consumers should be wary of dietary supplement products making unsubstantiated claims regarding the prevention and treatment of COVID-19.

Nov 12, 2020

Article

Despite the challenges of COVID-19 in 2020, CHPA remained hard at work on behalf of its members.

Nov 5, 2020

Filter Results